The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial.
Laurence WeinbergMichael Hua-Gen LiLeonid ChurilovChristopher MacgregorKent GarrettJade EylesRinaldo BellomoPublished in: PloS one (2021)
Registry: Australian New Zealand Clinical Trials Registry; ACTRN12613001042730; URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364988.
Keyphrases
- clinical trial
- phase iii
- phase ii
- patients undergoing
- open label
- study protocol
- double blind
- minimally invasive
- coronary artery bypass
- placebo controlled
- randomized controlled trial
- uric acid
- coronary artery disease
- metabolic syndrome
- percutaneous coronary intervention
- surgical site infection
- gold nanoparticles
- acute coronary syndrome
- atrial fibrillation
- reduced graphene oxide